Nova Scotia Health Authority Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2009
NCT00905853
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ayhman Al Afif | David Anderson | David Clarke | David Tang | John Sapp | Kenneth Rockwood | Marcelo Nicolela | Rudolf Uher